The charts in this car stock look attractive after months of trading in a range, says Jay Woods

GM has rallied nearly 70% over the past 52 weeks and is now being framed as a constructive technical setup, with support at $74-$79, a stop at $72, and an upside target of $98 if it breaks above $84. The article highlights improving fundamentals, stronger relative performance, and a new defense collaboration with Lockheed Martin as potential catalysts. Near-term impact is mainly stock-specific and technical rather than broad market-moving.

Analysis

GM’s important second-order story is not the chart pattern itself; it is the market’s willingness to re-rate a cyclical auto OEM into a capital-return and optionality compounder. If defense becomes even a modest recurring revenue stream, the stock can begin to trade less on peak unit volumes and more on mix, margin durability, and free cash flow stability — a meaningful multiple expansion catalyst if the market starts to underwrite a higher trough EBIT margin. The near-term setup suggests investors are already pricing improved execution, but not yet paying for the defense embeddedness or for the possibility that GM’s software/industrial capabilities become more monetizable outside consumer autos.

The competitive angle is subtle: a defense collaboration can improve GM’s perception with suppliers, engineers, and government customers, potentially helping procurement leverage and talent retention in advanced manufacturing. That said, the real beneficiary may be LMT’s ecosystem, because GM can provide cost-efficient production know-how that defense primes increasingly lack; if successful, this could pressure other industrials to pursue similar partnerships. For auto peers, the message is negative relative to lower-quality names: GM is trying to escape the “volume-only” bucket, while weaker OEMs remain trapped in a commodity pricing model with less cash to return.

The key risk is timing mismatch. Technical strength can fail quickly if the market realizes the defense relationship is more narrative than P&L, or if auto demand softens and gross margin leverage deteriorates before any new revenue stream contributes. Over the next 1-3 months, the stock likely trades as a momentum name; over 6-18 months, the valuation case only works if GM can show this is the start of a broader industrial diversification story rather than a one-off headline.

Key Decisions for Investors

• GM: Buy on a confirmed close above $84, with a 3-6 month target of $98; use $72 as a hard stop. Risk/reward is attractive only if breakout volume expands, otherwise it is likely a failed momentum trade.
• GM: For tactical exposure, consider a bullish call spread (e.g., 3-6 month upside structure) financed with limited premium; this captures the breakout without overpaying if the defense narrative takes time to monetize.
• LMT/GM pair: Long GM vs. small short LMT hedge if the market begins rewarding industrial optionality over pure defense duration. Thesis is that GM has more multiple upside if the partnership is viewed as strategic rather than incremental.
• Auto basket relative trade: Long GM, short a weaker legacy OEM or supplier proxy over 3-6 months. The goal is to express quality dispersion as investors increasingly prefer balance-sheet strength and shareholder returns over pure cyclical beta.
• Risk control: If GM loses the rising 200-day and cannot reclaim it within 2-3 sessions, reduce exposure quickly. That failure would signal the market is rejecting the new narrative and reclassifying the move as post-rally digestion rather than accumulation.